Retraction Note: Valsartan reduces AT1-AA-induced apoptosis through suppression oxidative stress mediated ER stress in endothelial progenitor cells.

IF 3.3 4区医学 Q1 Medicine

European review for medical and pharmacological sciences Pub Date : 2024-07-01 DOI:10.26355/eurrev_202407_36582

Z-C Wang, J Qi, L-M Liu, J Li, H-Y Xu, B Liang, B Li

{"title":"Retraction Note: Valsartan reduces AT1-AA-induced apoptosis through suppression oxidative stress mediated ER stress in endothelial progenitor cells.","authors":"Z-C Wang, J Qi, L-M Liu, J Li, H-Y Xu, B Liang, B Li","doi":"10.26355/eurrev_202407_36582","DOIUrl":null,"url":null,"abstract":"<p><p>The article \"Valsartan reduces AT1-AA-induced apoptosis through suppression oxidative stress mediated ER stress in endothelial progenitor cells\" by Z.-C. Wang, J. Qi, L.-M. Liu, J. Li, H.-Y. Xu, B. Liang, B. Li, published in Eur Rev Med Pharmacol Sci 2017; 21 (5): 1159-1168 - PMID: 28338173 has been retracted by the Editor in Chief. Following some concerns raised on PubPeer (link: https://pubpeer.com/publications/8FA8D4C63DE61DDB6C89537AD04B24), the Editor in Chief has started an investigation to assess the validity of the results as well as possible figure manipulation. The authors have been informed about the journal's investigation but remained unresponsive and have not provided the study's raw data. The journal's investigation revealed a Figure duplication in Figure 2C between panels AT1-AA (2.5 µM), AT1-AA (5 µM), AT1-AA (10 µM), and AT1-AA+Valsartan. Consequently, the Editor in Chief mistrusts the results presented and has decided to retract the article. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/12342.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"28 14","pages":"3970"},"PeriodicalIF":3.3000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European review for medical and pharmacological sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26355/eurrev_202407_36582","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

The article "Valsartan reduces AT1-AA-induced apoptosis through suppression oxidative stress mediated ER stress in endothelial progenitor cells" by Z.-C. Wang, J. Qi, L.-M. Liu, J. Li, H.-Y. Xu, B. Liang, B. Li, published in Eur Rev Med Pharmacol Sci 2017; 21 (5): 1159-1168 - PMID: 28338173 has been retracted by the Editor in Chief. Following some concerns raised on PubPeer (link: https://pubpeer.com/publications/8FA8D4C63DE61DDB6C89537AD04B24), the Editor in Chief has started an investigation to assess the validity of the results as well as possible figure manipulation. The authors have been informed about the journal's investigation but remained unresponsive and have not provided the study's raw data. The journal's investigation revealed a Figure duplication in Figure 2C between panels AT1-AA (2.5 µM), AT1-AA (5 µM), AT1-AA (10 µM), and AT1-AA+Valsartan. Consequently, the Editor in Chief mistrusts the results presented and has decided to retract the article. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/12342.

查看原文本刊更多论文

撤稿说明：缬沙坦通过抑制氧化应激介导的内皮祖细胞ER应激，减少AT1-AA诱导的细胞凋亡。

文章 "缬沙坦通过抑制内皮祖细胞氧化应激介导的ER应激减少AT1-AA诱导的细胞凋亡 "的作者是Z.-C. Wang, J. Qi, L.-M.Wang, J. Qi, L.-M. Liu, J. Li, H.-M.Liu, J. Li, H.-Y. Xu, B. Liang, B.-Y.Xu, B. Liang, B. Li》，发表于《Eur Rev Med Pharmacol Sci 2017; 21 (5)：1159-1168 - PMID: 28338173 已被主编撤回。在PubPeer（链接：https://pubpeer.com/publications/8FA8D4C63DE61DDB6C89537AD04B24）上提出了一些问题后，主编已开始调查，以评估结果的有效性以及可能存在的数字篡改。本刊已将调查情况告知作者，但作者一直没有回应，也没有提供研究的原始数据。期刊调查发现，图2C中的AT1-AA（2.5 µM）、AT1-AA（5 µM）、AT1-AA（10 µM）和AT1-AA+缬沙坦之间存在重复。因此，主编对所提供的结果不信任，决定撤回这篇文章。这篇文章已被撤回。出版商对由此造成的不便深表歉意。https://www.europeanreview.org/article/12342。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European review for medical and pharmacological sciences 医学-药学

CiteScore

5.30

自引率

6.10%

发文量

906

审稿时长

2-4 weeks

期刊介绍： European Review for Medical and Pharmacological Sciences, a fortnightly journal, acts as an information exchange tool on several aspects of medical and pharmacological sciences. It publishes reviews, original articles, and results from original research. The purposes of the Journal are to encourage interdisciplinary discussions and to contribute to the advancement of medicine. European Review for Medical and Pharmacological Sciences includes: -Editorials- Reviews- Original articles- Trials- Brief communications- Case reports (only if of particular interest and accompanied by a short review)